NEUP (Neuphoria Therapeutics) Other Long Term Assets : $0.07 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics Other Long Term Assets?

Neuphoria Therapeutics's other long-term assets for the quarter that ended in Dec. 2024 was $0.07 Mil.

Neuphoria Therapeutics's quarterly other long-term assets increased from Jun. 2024 ($0.08 Mil) to Sep. 2024 ($0.08 Mil) but then stayed the same from Sep. 2024 ($0.08 Mil) to Dec. 2024 ($0.07 Mil).

Neuphoria Therapeutics's annual other long-term assets declined from Jun. 2022 ($0.08 Mil) to Jun. 2023 ($0.08 Mil) and declined from Jun. 2023 ($0.08 Mil) to Jun. 2024 ($0.08 Mil).

Neuphoria Therapeutics Other Long Term Assets Historical Data

The historical data trend for Neuphoria Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuphoria Therapeutics Other Long Term Assets Chart

Neuphoria Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long Term Assets

Get a 7-Day Free Trial

0.30

0.09

0.08

Neuphoria Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															-	-	0.08	0.08	0.07

Neuphoria Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Neuphoria Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Summit Dr, Burlington, MA, USA, 01803

Website

https://www.bionomics.com.au

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.